drugset / Trial / NCT06866977
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer
Phase 1/2
Not yet recruiting
10 enrolled
Xiangya Hospital of Central South University
Guangzhou Virotech Pharmaceutical Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, single-arm, open label investigator-initiated clinical study to evaluate the efficacy and safety of VRT106 in combination with chemotherapy in the treatment of advanced pancreatic cancer.
Timeline
- Start
- 2025-03-12
- Primary completion
- 2025-10-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VRT106 | Unknown | — | Intravenous |